Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01

Weiner, January; Suwalski, Phillip; Holtgrewe, Manuel; Rakitko, Alexander; Thibeault, Charlotte; Müller, Melina; Patriki, Dimitri; Quedenau, Claudia; Krüger, Ulrike; Ilinsky, Valery; Popov, Iaroslav; Balnis, Joseph; Jaitovich, Ariel; Helbig, Elisa T.; Lippert, Lena J.; Stubbemann, Paula; Real, Luis M.; Macías, Juan; Pineda, Juan A.; Fernández-Fuertes, Marta; Wang, Xiaomin; Karadeniz, Zehra; Saccomanno, Jacopo; Doehn, Jan Moritz; Hübner, Ralf Harto; Hinzmann, Bernd; Salvo, Mauricio; Blueher, Anja; Siemann, Sandra; Jurisic, Stjepan; Beer, Juerg H.; Rutishauser, Jonas; Wiggli, Benedikt; Schmid, Hansruedi; Danninger, Kathrin; Binder, Ronald; Corman, Victor M.; Mühlemann, Barbara; Arjun Arkal, Rao; Fragiadakis, Gabriela K.; Mick, Eran; Calfee, Carolyn S.; Erle, David J.; Hendrickson, Carolyn M.; Kangelaris, Kirsten N.; Krummel, Matthew F.; Woodruff, Prescott G.; Langelier, Charles R.; Venkataramani, Urmila; García, Federico; Zyla, Joanna; Drosten, Christian; Alice, Braun; Jones, Terry C.; Suttorp, Norbert; Witzenrath, Martin; Hippenstiel, Stefan; Zemojtel, Tomasz; Skurk, Carsten; Poller, Wolfgang; Borodina, Tatiana; Pa-COVID, Study Group; Ripke, Stephan; Sander, Leif E.; Beule, Dieter; Landmesser, Ulf; Guettouche, Toumy; Kurth, Florian; Heidecker, Bettina

Autoría grupal: Consortium COMET

Tipo: Artículo
Año de Publicación: 2021
Volumen: 40
Número de artículo: 101099
Acceso abierto: Vía dorada
Fuente Nº Citas Fecha Actualización
scopus2228-01-2023
wos2328-01-2023
Dimensions
PlumX
Altmetric

Año: 2021

Journal Impact Factor (JIF): 17.033

CategoríaEdiciónPosiciónCuartilTercilDecil
MEDICINE, GENERAL & INTERNALSCIE12/172Q1T1D1

Año:

2021

CiteScore:

10.900

CategoríaPosiciónCuartilTercilDecil
Medicine (all)35/826Q1T1D1

SJR año:

2021

Factor de Impacto:

4.657

CategoríaPosiciónCuartilTercilDecil
Medicine (miscellaneous)39/2488Q1T1D1
No existen datos para la revista de esta publicación.
Agencia Código de Proyecto
Berlin Institute of Health (CM-COVID)-
Berlin Institutes of Health (B.I.H.)-
German Ministry of Education and Research (BMBF)01ZX1304B; 01ZX1604B; 01ZX1906A; 01KI20160A; 16GW0141; 16GW0247; 01KX2021
German Research FoundationSFB-TR84; SFB 1449
German Research Foundation (DFG)-
National Institutes of Health: NIHK01-HL130704
NIAID-NIH CEIRS contractHHSN272201400008C
NIHR35 HL140026
Open Access Publication Fund of Charite - Universitatsmedizin Berlin-
Roche Sequencing Solutions, Inc.-
Silesian University of Technology grant for Support and Development of Research Potential-
Swiss National Science Foundation-
Nota: los datos sobre financiación provienen de la WOS
# Autor Afiliación
1Weiner, JanuaryBerliner Institut für Gesundheitsforschung (Germany)
2Suwalski, PhillipCharité – Universitätsmedizin Berlin; Berliner Simulations- und Trainingszentrum (Germany)
3Holtgrewe, ManuelBerliner Institut für Gesundheitsforschung (Germany)
4Rakitko, AlexanderGenotek Ltd. (Russian Federation)
5Thibeault, CharlotteCharité – Universitätsmedizin Berlin (Germany)
6Müller, MelinaCharité – Universitätsmedizin Berlin (Germany)
7Patriki, DimitriKantonsspital Baden AG (Germany)
8Quedenau, ClaudiaMax Delbruck Center for Molecular Medicine (Germany)
9Krüger, UlrikeBerliner Institut für Gesundheitsforschung (Germany)
10Ilinsky, ValeryGenotek Ltd. (Russian Federation)
11Popov, IaroslavGenotek Ltd. (Russian Federation)
12Balnis, JosephAlbany Medical College (United States)
13Jaitovich, ArielAlbany Medical College (United States)
14Helbig, Elisa T.Charité – Universitätsmedizin Berlin (Germany)
15Lippert, Lena J.Charité – Universitätsmedizin Berlin (Germany)
16Stubbemann, PaulaCharité – Universitätsmedizin Berlin (Germany)
17Real, Luis M.Hospital Universitario de Valme (Spain)
18Macías, JuanHospital Universitario de Valme (Spain)
19Pineda, Juan A.Hospital Universitario de Valme (Spain)
20Fernández-Fuertes, MartaHospital Universitario de Valme (Spain)
21Wang, XiaominCharité – Universitätsmedizin Berlin (Germany)
22Karadeniz, ZehraCharité – Universitätsmedizin Berlin (Germany)
23Saccomanno, JacopoCharité – Universitätsmedizin Berlin (Germany)
24Doehn, Jan MoritzCharité – Universitätsmedizin Berlin (Germany)
25Hübner, Ralf HartoCharité – Universitätsmedizin Berlin (Germany)
26Hinzmann, BerndRoche Sequencing Solutions (United States)
27Salvo, MauricioRoche Sequencing Solutions (United States)
28Blueher, AnjaRoche Sequencing Solutions (United States)
29Siemann, SandraRoche Sequencing Solutions (United States)
30Jurisic, StjepanKantonsspital Baden AG (Germany)
31Beer, Juerg H.Kantonsspital Baden AG (Germany)
32Rutishauser, JonasKantonsspital Baden AG (Germany)
33Wiggli, BenediktKantonsspital Baden AG (Germany)
34Schmid, HansruediKantonsspital Baden AG (Germany)
35Danninger, KathrinKlinikum Wels - Grieskirchen GmbH (Austria)
36Binder, RonaldKlinikum Wels - Grieskirchen GmbH (Austria)
37Corman, Victor M.Charité – Universitätsmedizin Berlin (Germany)
38Mühlemann, BarbaraCharité – Universitätsmedizin Berlin (Germany)
39Arjun Arkal, RaoUniversity of California, San Francisco; Department of Pathology (United States)
40Fragiadakis, Gabriela K.University of California, San Francisco (United States)
41Mick, EranUniversity of California, San Francisco; Chan Zuckerberg Biohub (United States)
42Calfee, Carolyn S.University of California, San Francisco (United States)
43Erle, David J.University of California, San Francisco; COMET (COVID-19 Multiphenotyping for Effective Therapies) Consortium members are listed in the Supplementary Appendix 1 (United States)
44Hendrickson, Carolyn M.University of California, San Francisco (United States)
45Kangelaris, Kirsten N.University of California, San Francisco (United States)
46Krummel, Matthew F.University of California, San Francisco; Department of Pathology (United States)
47Woodruff, Prescott G.University of California, San Francisco; Department of Pathology (United States)
48Langelier, Charles R.University of California, San Francisco; Chan Zuckerberg Biohub (United States)
49Venkataramani, UrmilaUniversity of California, San Francisco (United States)
50García, FedericoHospital Universitario San Cecilio (Spain)
51Zyla, JoannaSilesian University of Technology (Poland)
52Drosten, ChristianCharité – Universitätsmedizin Berlin (Germany)
53Alice, BraunCharité – Universitätsmedizin Berlin (Germany)
54Jones, Terry C.University of Cambridge; German Centre for Infection Research (DZIF); Charité – Universitätsmedizin Berlin (United Kingdom)
55Suttorp, NorbertCharité – Universitätsmedizin Berlin (Germany)
56Witzenrath, MartinCharité – Universitätsmedizin Berlin (Germany)
57Hippenstiel, StefanCharité – Universitätsmedizin Berlin (Germany)
58Zemojtel, TomaszBerliner Institut für Gesundheitsforschung (Germany)
59Skurk, CarstenCharité – Universitätsmedizin Berlin (Germany)
60Poller, WolfgangCharité – Universitätsmedizin Berlin (Germany)
61Borodina, TatianaMax Delbruck Center for Molecular Medicine (Germany)
62Pa-COVID, Study GroupPa-COVID Study Group (None)
63Ripke, StephanMassachusetts General Hospital; Broad Institute; Charité – Universitätsmedizin Berlin (United States)
64Sander, Leif E.Charité – Universitätsmedizin Berlin (Germany)
65Beule, DieterBerliner Institut für Gesundheitsforschung (Germany)
66Landmesser, UlfCharité – Universitätsmedizin Berlin; Berliner Institut für Gesundheitsforschung (Germany)
67Guettouche, ToumyRoche Sequencing Solutions (United States)
68Kurth, FlorianCharité – Universitätsmedizin Berlin (Germany)
69Heidecker, BettinaCharité – Universitätsmedizin Berlin (Germany)
# Autoría grupal Afiliación
1Consortium COMETCOMET (COVID-19 Multiphenotyping for Effective Therapies) Consortium members are listed in the Supplementary Appendix 1 (None)